"and ymav4294, that is correct. Prima are enrolling patients from the point of diagnosis to monitor their treatment through surgery and chemo before Cvac treatment begins."-DCHECKERS
Yes that is my understanding also. However they are taking the dendritic cells(immune) from the patient BEFORE chemo when the immune response will be stonger - and administering the CVAC (treated dendritic cells) AFTER chemo--Martin Rogers made a point of mentioning this to me and it is mentioned elsewhere in public documents.
cheers
Birdseye
sydney shareholder presentation, page-6
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.3¢ |
Change
0.013(4.31%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $359.1K | 1.205M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 72088 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 338711 | 21 |
View Market Depth
| Last trade - 14.23pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |